These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38944250)

  • 21. Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients.
    Pan J; Yan X; Li F; Zhang Y; Jiang L; Wang C
    J Diabetes Investig; 2022 Feb; 13(2):328-335. PubMed ID: 34455710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes.
    Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Hur KY; Lee MK; Jin SM; Kim JH
    Diabetes Metab Res Rev; 2019 Feb; 35(2):e3092. PubMed ID: 30345631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes.
    Vianna AGD; Lacerda CS; Pechmann LM; Polesel MG; Marino EC; Faria-Neto JR
    Diabetes Res Clin Pract; 2018 May; 139():357-365. PubMed ID: 29596951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated glucose disposal rate predicts the risk of diabetic peripheral neuropathy in type 2 diabetes: A 5-year follow-up study.
    Zhang Y; Sun W; Zhang Q; Bai Y; Ji L; Zheng H; Zhu X; Liu X; Zhang S; Xiong Q; Li Y; Chen L; Lu B
    J Diabetes; 2024 May; 16(5):e13482. PubMed ID: 38225901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
    Šoupal J; Škrha J; Fajmon M; Horová E; Mráz M; Škrha J; Prázný M
    Diabetes Technol Ther; 2014 Apr; 16(4):198-203. PubMed ID: 24401008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.
    Tsuchiya T; Saisho Y; Murakami R; Watanabe Y; Inaishi J; Itoh H
    Endocr J; 2020 Aug; 67(8):877-881. PubMed ID: 32389920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
    Kohnert KD; Heinke P; Fritzsche G; Vogt L; Augstein P; Salzsieder E
    Diabetes Technol Ther; 2013 Jun; 15(6):448-54. PubMed ID: 23550553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis.
    Hjort A; Iggman D; Rosqvist F
    Clin Nutr; 2024 Apr; 43(4):915-925. PubMed ID: 38401227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there an association between non-dipping blood pressure and measures of glucose variability in type 1 diabetes?
    Jaiswal M; Ang L; Mizokami-Stout K; Pop-Busui R
    J Diabetes Complications; 2018 Oct; 32(10):947-950. PubMed ID: 30087063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.
    Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ
    Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of glycemic variability and hypoglycemia with distal symmetrical polyneuropathy in adults with type 1 diabetes.
    Shen Z; Jiang H; Huang R; Zhou Y; Li Q; Ma J
    Sci Rep; 2021 Nov; 11(1):22875. PubMed ID: 34819569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.
    Breyton AE; Lambert-Porcheron S; Laville M; Vinoy S; Nazare JA
    Front Endocrinol (Lausanne); 2021; 12():666008. PubMed ID: 34566883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-Analysis.
    Mu ZP; Wang YG; Li CQ; Lv WS; Wang B; Jing ZH; Song XJ; Lun Y; Qiu MY; Ma XL
    Mol Neurobiol; 2017 Mar; 54(2):983-996. PubMed ID: 26797519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic Peripheral Neuropathy in Ethiopia: A Systematic Review and Meta-Analysis.
    Tadesse DB; Gebrewahd GT; Hailay A; Aberhe W; Mebrahtom G; Zereabruk K; Gebreayezgi G; Mariye T; Haile TG; Gebremeskel GG; Demoz GT
    J Diabetes Res; 2021; 2021():5304124. PubMed ID: 33628833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of glycemic variability on diabetic peripheral neuropathy.
    Jin HY; Lee KA; Park TS
    Endocrine; 2016 Sep; 53(3):643-8. PubMed ID: 27383181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic variability leads to higher levels of auto-oxidized oxysterol species in patients with type 1 diabetes mellitus.
    Ünlütürk U; Bahçecioğlu AB; Samadi A; Lay I; Bayraktar M; Dağdelen S
    J Endocrinol Invest; 2023 Dec; 46(12):2547-2554. PubMed ID: 37188911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review.
    Gouveri E; Papanas N
    Diabetes Ther; 2022 May; 13(5):931-952. PubMed ID: 35394566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
    Mayeda L; Katz R; Ahmad I; Bansal N; Batacchi Z; Hirsch IB; Robinson N; Trence DL; Zelnick L; de Boer IH
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.